Rockwell Medical (RMTI) Other financing activities (2012 - 2019)

Rockwell Medical (RMTI) posted Other financing activities of $100.0 for Q3 2019, down 99.93% on a QoQ basis from $147900.0 in Q1 2019.

Rockwell Medical (RMTI) Other financing activities (2012 - 2019) Analysis & Trends

Rockwell Medical's Other financing activities history runs 2 years deep, the most recent figure standing at $100.0 for Q3 2019.

Quarterly Other financing activities changed N/A year-over-year to $100.0 in Q3 2019, while the trailing twelve-month figure through Jun 2020 was $100.0 (changed N/A YoY) and the FY2021 annual result came in at $107000.0, changed N/A from the prior year.
Other financing activities was $100.0 for Q3 2019 at Rockwell Medical, down from $147900.0 in the prior quarter.
Across five years, Other financing activities topped out at $147900.0 in Q1 2019 and bottomed at $100.0 in Q3 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Rockwell Medical	25.77 Mn	1.88 Mn	2.90 Mn

Download Data